BDTX
Black Diamond Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.81
+5.23%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- $8.3M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.17
- EPS estimate
- -$0.20
- Revenue actual
- —
- Revenue estimate
- $5.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +19.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.20 | -$0.17 | Beat 13.02% | — |
| May 7, 2026 | -$0.18 | -$0.16 | Beat 11.11% | — |
| Mar 16, 2026 | -$0.18 | -$0.14 | Beat 21.74% | — |
| Nov 6, 2025 | -$0.22 | -$0.15 | Beat 31.82% | — |
| Aug 7, 2025 | -$0.25 | -$0.19 | Beat 24.00% | — |
| Mar 6, 2025 | -$0.31 | -$0.28 | Beat 9.68% | — |
| May 9, 2024 | -$0.44 | -$0.35 | Beat 20.45% | — |
| Mar 12, 2024 | -$0.47 | -$0.34 | Beat 27.66% | $4.9M |
| Aug 11, 2023 | -$0.54 | -$0.52 | Beat 3.70% | — |
| Mar 9, 2023 | -$0.63 | -$0.59 | Beat 6.35% | — |
| Mar 17, 2022 | -$1.01 | -$0.71 | Beat 29.70% | — |
| Aug 12, 2021 | -$0.87 | -$0.95 | Miss -9.20% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026